Company Filing History:
Years Active: 1993-2001
Title: Michael Berger: Innovator in Immunoassay Technology
Introduction
Michael Berger is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of immunoassays, particularly through his innovative methods and technologies. With a total of 3 patents to his name, Berger continues to push the boundaries of scientific research and application.
Latest Patents
One of Michael Berger's latest patents is a "Method for carrying out a homogeneous-immunoassay based on agglutination." This invention focuses on a homogeneous immunoassay that utilizes an Fab′-biotin material and agglutinatable particles that carry streptavidin or avidin. The patent also describes the Fab′-biotin linked to a label compound capable of electrochemiluminescence, with the particles featuring magnetic properties.
Another significant patent is for the "Preparation of a solid phase matrix containing a bound specific binding." This invention involves binding a specific binding pair to an insoluble carrier for analyte determination, such as in immunoassays. The carrier is coated with a polymer containing a protein polymer of considerable molecular weight, facilitating the binding of the specific binding pair members. The innovative approach enhances the efficiency and effectiveness of immunoassays.
Career Highlights
Michael Berger is currently employed at Boehringer Mannheim GmbH, where he applies his expertise in immunoassay technology. His work has been instrumental in advancing the company's research and development efforts in this critical area of healthcare.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Arno Deger and Josef Maier. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Berger's contributions to immunoassay technology exemplify his dedication to scientific advancement. His innovative patents and collaborative efforts continue to impact the field positively.